- 210 -
7.
To instruct the Executive Secretariat of CICAD:
a.
To continue to provide assistance to member states that request it to facilitate
compliance with the recommendations that flow from the application of the
Multilateral Evaluation Mechanism;
b.
To endeavor to set priorities for the programs carried out by CICAD in all
areas, in accordance with the needs of member states; and to explore new
technologies and other measures to reduce costs with a view to adjusting to
the current financial problems of the Organization;
c.
To promote adoption of the CICAD Model Regulations for the Control of the
International Movement of Firearms, Their Parts and Components, and
Ammunition, especially the provisions concerning firearms brokers, adopted
at the thirty-fourth regular session of CICAD, held in Montreal, and to
advance in the implementation of the Small Arms and Light Weapons
Administration System (SALSA) program as an instrument for improving
application of the controls set out in the Model Regulations as well as those
of the Inter-American Convention against the Illicit Manufacturing of and
Trafficking in Firearms, Ammunition, Explosives, and Other Related
Materials (CIFTA);
d.
To continue its training and technical assistance programs and other activities
such as mock trials which focus on criminal procedure to facilitate
prosecution of money laundering offenses;
e.
To continue to make efforts to provide technical and financial assistance to
member states, with the goal of consolidating the different aspects of
institutional and legal strengthening in the field of drug control;
f.
To continue to promote the creation and strengthening of National Drug
Observatories, or national information and research systems on drugs, which
are fundamental tools for the strategic planning of national drug policies;
g.
Through the Inter-American Observatory on Drugs, to support member states
in the development and maintenance of uniform data collection systems on
the problem of drug use at the national level, in order to be able to measure
the problem and follow up on new trends in drug abuse;
h.
To help member states strengthen control measures to prevent the diversion
of pharmaceutical products, controlled chemical substances, and illicitly
produced synthetic drugs, and improve the exchange of information on
matters related to the application of control measures, in accordance with the
plans of action of the Expert Group on Chemicals and the Expert Group on
Pharmaceutical Products, as approved at the thirty-fourth regular session of
the Commission;
Select target paragraph3
Connect to a paragraph
Connect to an entity
Disable highlights
Add to table of contents